AstraZeneca is in talks with Summit Therapeutics to license an experimental lung-cancer drug under a deal worth as much as ...

AstraZeneca PLC (NASDAQ:AZN) is one of the 11 Best Strong Buy Stocks to Invest in Now. On June 13, AstraZeneca PLC (NASDAQ:AZN) announced that it had entered into a strategic research ...

AstraZeneca PLC closed 23.78% short of its 52-week high of £133.88, which the company achieved on September 3rd.

Astrazeneca (AZN) closed the most recent trading day at $71.46, moving +2.26% from the previous trading session. The stock's performance was ahead of the S&P 500's daily loss of 0.11%. Elsewhere ...

AstraZeneca is considering moving its stock market listing from London, where it is the exchange's most valuable company, to ...

See the latest AstraZeneca PLC ADR stock price (AZN:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

AstraZeneca outperforms markets YTD amid eased concerns, China clarity, minimal US tariff impact, and attractive valuations. Learn more on AZN stock here.

Astrazeneca (AZN) closed the most recent trading day at $71.46, moving +2.26% from the previous trading session. The stock's performance was ahead of the S&P 500's daily loss of 0.11%. Elsewhere, the ...

AstraZeneca PLC closed 22.30% short of its 52-week high of £133.88, which the company reached on September 3rd.

AstraZeneca PLC (NASDAQ:AZN) is one of the 12 stocks that will make you rich in 10 years. On June 23, the company announced that the FDA had granted accelerated approval to Datroway for the ...